MedPage Today September 18, 2023
Judy George

— Privacy policies, terms of sale often are unclear

Direct-to-consumer (DTC) laboratory tests — for the thyroid, hormonal biomarkers, or diabetes and hemoglobin A1c, for example — often had unclear terms of sale and vague privacy policies, a qualitative study showed.

Of 21 U.S. companies that offered DTC lab tests, less than half declared compliance with the Health Insurance Portability and Accountability Act (HIPAA), and less than a quarter specified protections for biological samples, according to Louiza Kalokairinou, PhD, of the Baylor College of Medicine Center for Medical Ethics and Health Policy in Houston, and co-authors.

More than half stated consumer data potentially could be used for research purposes, either internally or through a third party, Kalokairinou and colleagues reported...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, HIPAA, Patient / Consumer, Privacy / Security, Provider
The Cost of Ignoring Women’s Health Extends Beyond Finances: Sarah Ahmad
Why bone marrow transplants are becoming less common
Peer Caregiving In Prisons: A Humane Response To A Growing Health Care Crisis
The Physician's Role in Curing the Social Media Epidemic
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time

Share This Article